Citation

Dwight E. Yin, Stephen R. Cole, Christina Ludema, M. Alan Brookhart, Carol E. Golin, William C. Miller, Ross E. McKinney. A Per-Protocol Analysis using Inverse Probability of Censoring Weights in a Randomized Trial of Initial PI versus NNRTI Regimens in Children. American Journal Of Epidemiology. 2023. 192: 916-928. PMID: 36896583

Citation

Haseena Cassim, Kevin Ryan, Jaime G. Deville, Hardik Chandasana, Ponego L. Ponatshego, Cynthia H. Brothers, Faeezah Patel, Ann M. Buchanan, Linda Aurpibul, Helena Rabie, Shaun L. Barnabas, Patricia M. Flynn, Iris Mustich, IMPAACT 2019 Study Team, Anne Coletti, Barbara Heckman, Kristina M. Brooks, Chelsea Krotje, Jennifer J. Kiser, Mark Lojacono, Lauren Ziemba, Dwight E. Yin, Shawn Ward, Ellen Townley, Yasha Rani, Jack Moye, Tim R. Cressey, Sai Majji, Gaerolwe R. Masheto, Edward P. Acosta. Pharmacokinetics, Safety, and Tolerability of Dispersible and Immediate-Release Abacavir, Dolutegravir and Lamivudine Tablets in Children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study. Lancet HIV. 2023. 10: E506-E517. PMID: 37541705

Citation

IMPAACT P1078 TB APPRISE Study Team, Aisa Shayo, Tsungai Chipato, Gerhard Theron, Lynda Stranix-Chibanda, Adriana Weinberg, Vongai Chanaiwa, Tichaona Vhembo, Mercy Mutambanengwe, Gaerolwe Masheto, Mpho Raesi, Sarah Bradford, Amanda Golner, Diane Costello, Vandana Kulkarni, Amita Gupta, Enid Kabugho, Priya Singh, Patrick Jean–Phillippe, Lisa Aaron, Nahida Chakhtoura, Grace Montepiedra, Timothy R. Sterling. Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial. Lancet Child and Adolescent Health. 2023. 7: 708-717. PMID: 37634517

Citation

Tim R. Cressey, David E. Shapiro, Kira Bacon, Kevin Knowles, Kathleen George, Renee Browning, Nahida Chakhtoura, Kittipong Rungruengthanakit, Lubbe Wiesner, Marije Van Schalkwyk, Edmund V. Capparelli, Adrie Bekker, Alice M. Stek, Eric Decloedt, Mark Mirochnick, Jiajia Wang, Brookie M. Best, Gerhard B. Theron, IMPAACT P1026s Protocol Team, Mark F. Cotton, Ahizechukwu C. Eke. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s. Journal Antimicrobial Agents and Chemotherapy. 2023. 67: e0073723. PMID: 37882552

Citation

Jeremiah D. Momper, Mina Nikanjam, Brookie M. Best, Mark Mirochnick, Edmund V. Capparelli, Tim R. Cressey. Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum. Journal of Acquired Immune Deficiency Syndromes. 2023. 94: 332-336. PMID: 37884053

Citation

Alice M. Stek, David E. Shapiro, Emily Barr, Irma L. Febo, Mary E. Paul, Jaime G. Deville, Kathleen George, Kevin Knowles, Kittipong Rungruengthanakit, Renee Browning, Nahida Chakhtoura, Edmund V. Capparelli, Mark Mirochnick, Brookie M. Best, Kristina M. Brooks, IMPAACT P1026s Protocol Team, Mauricio Pinilla. Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. Journal of Acquired Immune Deficiency Syndromes. 2022. 90: 343-350. PMID: 35195573

Citation

Lee Fairlie, Kathleen George, Barbra Heckman, Kevin Knowles, Renee Browning, George K Siberry, Taha E Taha, Lynda Stranix-Chibanda, PROMISE P1084s Study Team, Camlin Tierney, Mary Glenn Fowler, Dhayendre Moodley, Gerhard Theron, Lynette H Nyakudya, Musunga Tomu, Kristin Baltrusaitis, Bonus Makanani. Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial. BMC Infectious Diseases. 2022. 22: 634. PMID: 35858874

Citation

Andrew Wiznia, Nicole Montañez, Keith Nangle, Joseph Horton, Ann Buchanan, Eugene Stewart, Paul Palumbo, Cindy Vavro, Theodore Ruel. Emergence of Resistance in HIV-1 Integrase With Dolutegravir Treatment in a Pediatric Population From the IMPAACT P1093 Study. Antimicrobial Agents and Chemotherapy. 2022. 66: e0164521. PMID: 34694878

Citation

Brookie M. Best, Edward Acosta, Mark Mirochnick, Diana F. Clarke, Edmund V. Capparelli, Jeremiah D. Momper, Joseph Piscitelli, Mina Nikanjam. Optimizing Dolutegravir Initiation in Neonates using Population Pharmacokinetic Modeling and Simulation. Journal of Acquired Immune Deficiency Syndromes. 2022. 89: 108-114. PMID: 34629412

Citation

David E Shapiro, Kathleen M Powis, Mary E Paul, Martina L Badell, Renee Browning, Nahida Chakhtoura, Kayla Denson, Kittipong Rungruengthanakit, Kathleen George, Edmund V Capparelli, Mark Mirochnick, Brookie M Best, Jeremiah D Momper, IMPAACT P1026s Protocol Team, Alice Stek, Kathleen Powis, Jiajia Wang. Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV. Journal of Acquired Immune Deficiency Syndromes. 2022. 89: 303-309. PMID: 34732682